European cancer epidemic could occur in next decade if health system weaknesses, cancer research not urgently addressed

byLancetKey findings of The Lancet Oncology Groundshot Commission. Credit: The LancetThe COVID-19 pandemic has exposed weaknesses in cancer health systems and in the cancer research landscape ac

Updated on: January 02,2024 9

European cancer epidemic could occur in next decade if health system weaknesses, cancer research not urgently addressed

byLancetKey findings of The Lancet Oncology Groundshot Commission. Credit: The LancetThe COVID-19 pandemic has exposed weaknesses in cancer health systems and in the cancer research landscape ac

Updated on:January 02,2024 9

Discovery boosts the potential of new cancer-fighting drugs

by The Scripps Research InstituteCancer cell during cell division. Credit: National Institutes of HealthScientists at Scripps Research have uncovered a critical feature that a promising new class

Updated on: February 23,2024 19

Discovery boosts the potential of new cancer-fighting drugs

by The Scripps Research InstituteCancer cell during cell division. Credit: National Institutes of HealthScientists at Scripps Research have uncovered a critical feature that a promising new class

Updated on:February 23,2024 19

Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulati

Updated on: January 22,2024 11

Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulati

Updated on:January 22,2024 11

New computer platform helps match patients with cancer to trials of targeted therapy

byDana-Farber Cancer InstituteMatchMiner overview of data flow and modes of use. a) Data inputs from patients and trials are utilized by the MatchEngine to match patients to trials. b) Shown are

Updated on: January 12,2024 10

New computer platform helps match patients with cancer to trials of targeted therapy

byDana-Farber Cancer InstituteMatchMiner overview of data flow and modes of use. a) Data inputs from patients and trials are utilized by the MatchEngine to match patients to trials. b) Shown are

Updated on:January 12,2024 10

Study: More aggressive treatments needed to improve 5-year survival rate for glioblastoma

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicDespite improvements in median and short-term survival rates for patients with glioblastoma, the most common brain tumor in adults, the percentage of

Updated on: May 27,2024 8

Study: More aggressive treatments needed to improve 5-year survival rate for glioblastoma

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicDespite improvements in median and short-term survival rates for patients with glioblastoma, the most common brain tumor in adults, the percentage of

Updated on:May 27,2024 8

Novel stem cell culture system could lead to future therapies for a variety of disorders

byUT Southwestern Medical CenterCredit:Cell(2023). DOI: 10.1016/j.cell.2023.11.008A new study led by UT Southwestern Medical Center molecular biologists presents a novel culture syst

Updated on: January 15,2024 20

Novel stem cell culture system could lead to future therapies for a variety of disorders

byUT Southwestern Medical CenterCredit:Cell(2023). DOI: 10.1016/j.cell.2023.11.008A new study led by UT Southwestern Medical Center molecular biologists presents a novel culture syst

Updated on:January 15,2024 20

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

by Cancer Research UKCredit: CC0 Public DomainA drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treat

Updated on: May 11,2024 4

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

by Cancer Research UKCredit: CC0 Public DomainA drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treat

Updated on:May 11,2024 4

Study reveals how diet and probiotics boost melanoma immunotherapy response

by University of PittsburghMarlies Meisel, Ph.D., assistant professor in the Department of Immunology at the University of Pittsburgh School of Medicine and member of the Cancer Immunology and Im

Updated on: February 23,2024 10

Study reveals how diet and probiotics boost melanoma immunotherapy response

by University of PittsburghMarlies Meisel, Ph.D., assistant professor in the Department of Immunology at the University of Pittsburgh School of Medicine and member of the Cancer Immunology and Im

Updated on:February 23,2024 10

DNA fragments in blood promise cheap, easy test for cancer

by Amy NortonResearchers are reporting progress on a blood test that can detect multiple cancers in a relatively simpler, and potentially less pricey way than other tests under development.The test pi

Updated on: January 15,2024 11

DNA fragments in blood promise cheap, easy test for cancer

by Amy NortonResearchers are reporting progress on a blood test that can detect multiple cancers in a relatively simpler, and potentially less pricey way than other tests under development.The test pi

Updated on:January 15,2024 11

Researchers discover new tool for improving pancreatic cancer care

by Champalimaud Centre for the UnknownCredit: Unsplash/CC0 Public DomainThe statistics for pancreatic cancer are sobering. With a five-year survival rate of only 9%, incidence of the most common type,

Updated on: February 23,2024 18

Researchers discover new tool for improving pancreatic cancer care

by Champalimaud Centre for the UnknownCredit: Unsplash/CC0 Public DomainThe statistics for pancreatic cancer are sobering. With a five-year survival rate of only 9%, incidence of the most common type,

Updated on:February 23,2024 18

Drug combination shows promise in preclinical models of triple negative breast cancer

by Alhaji Janneh,Medical University of South CarolinaYueying Liu and Dr. Antonio Giordano study PLK1 inhibitors, traffic light-like signals that stop the uncontrolled growth of breast cancer cel

Updated on: May 23,2024 7

Drug combination shows promise in preclinical models of triple negative breast cancer

by Alhaji Janneh,Medical University of South CarolinaYueying Liu and Dr. Antonio Giordano study PLK1 inhibitors, traffic light-like signals that stop the uncontrolled growth of breast cancer cel

Updated on:May 23,2024 7

People with type 2 diabetes at higher risk of certain cancers could be identified by a simple blood test, study suggests

byDiabetologiaCredit: Karolina Grabowska from PexelsIndividuals with type 2 diabetes who are at higher risk of certain cancers could be identified by a simple blood test, this year'sAn

Updated on: September 07,2024 0

People with type 2 diabetes at higher risk of certain cancers could be identified by a simple blood test, study suggests

byDiabetologiaCredit: Karolina Grabowska from PexelsIndividuals with type 2 diabetes who are at higher risk of certain cancers could be identified by a simple blood test, this year'sAn

Updated on:September 07,2024 0